欢迎来到《四川大学学报(医学版)》 2025年7月10日 星期四

非分泌型CXCL16在乳腺癌细胞系中的表达及对其生物学特性的影响

方业颖, 雷倩倩, 李燕, 陈念永

方业颖, 雷倩倩, 李燕, 等. 非分泌型CXCL16在乳腺癌细胞系中的表达及对其生物学特性的影响[J]. 四川大学学报(医学版), 2013, 44(4): 522-525,530.
引用本文: 方业颖, 雷倩倩, 李燕, 等. 非分泌型CXCL16在乳腺癌细胞系中的表达及对其生物学特性的影响[J]. 四川大学学报(医学版), 2013, 44(4): 522-525,530.
FANG Ye-ying, LEI Qian-qian, LI Yan, et al. Expression of Non-secretory CXCL16 and Its Impact on Biological Characteristics in Breast Cancer Cell Lines[J]. Journal of Sichuan University (Medical Sciences), 2013, 44(4): 522-525,530.
Citation: FANG Ye-ying, LEI Qian-qian, LI Yan, et al. Expression of Non-secretory CXCL16 and Its Impact on Biological Characteristics in Breast Cancer Cell Lines[J]. Journal of Sichuan University (Medical Sciences), 2013, 44(4): 522-525,530.

栏目: 论著

非分泌型CXCL16在乳腺癌细胞系中的表达及对其生物学特性的影响

基金项目: 

四川省科技支撑计划项目(No.2009SZ0146)资助

Expression of Non-secretory CXCL16 and Its Impact on Biological Characteristics in Breast Cancer Cell Lines

  • 摘要: 目的 通过检测非分泌型CXCL16在不同侵袭性乳腺癌细胞系(SK-BR-3、MCF-7、MDA-MB-231、MDA-MB-435S)及正常乳腺上皮细胞MCF-10A的表达,探讨非分泌型CXCL16表达对乳腺癌细胞生物学特性的影响。 方法 采用RT-PCR检测CXCL16 mRNA在MCF-10A、SK-BR-3、MCF-7、MDA-MB-231、MDA-MB-435S细胞系的表达,将pEGFP-CXCL16真核表达质粒转染到低表达CXCL16的MDA-MB-231细胞,通过实时荧光定量PCR和Western blot验证CXCL16过表达,采用体外迁移、侵袭实验及甲基四唑蓝(MTT)法分别检测过表达CXCL16对MDA-MB-231细胞迁移、侵袭和增殖活性的影响。 结果 CXCL16 mRNA在高侵袭性的MDA-MB-231细胞低表达,在低侵袭性的MCF-7细胞高表达,过表达CXCL16使得MDA-MB-231细胞的迁移、侵袭减弱,而增殖未受到影响。 结论 非分泌型CXCL16表达与乳腺癌细胞系的侵袭性相关,其表达可以抑制乳腺癌细胞的体外迁移、侵袭。

     

    Abstract: Objective To detect the expression of non-secretory CXCL16 and its impact on malignant biological behaviors in breast cancer cell lines. Methods RT-PCR was carried out to examine the expression of CXCL16 mRNA in breast cancer cell lines with different aggressiveness SK-BR-3, MCF-7, MDA-MB-231, MDA-MB-435S and human mammary normal epithelial celll MCF-10A. The eukaryotic expression plasmid of CXCL16 was transfected into MDA-MB-231 cells and overexpression of CXCL16 was confirmed by Real time PCR and Western blot. Boyden Chamber assay was used to determine cell migration and invasion, while MTT assay was performed to determine cell proliferation. Results Among four breast cancer cell lines, CXCL16 mRNA was highly expressed in MCF-7, lowly expressed in MDA-MB-231, while MCF-10A faintly expressed CXCL16. Overexpression of CXCL16 led to a decrease in cell migration, invasion but not proliferation in MDA-MB-231 cells. Conclusion Expression of non-secretory CXCL16 is associated with aggressiveness of breast cancer cell lines, and CXCL16 expression inhibits cell migration and invasion in vitro.

     

  • [1]

    Matloubian M, David A, Engel S, et al. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol, 2000;1(4):298-304.

    [2]

    Zlotnik A, Burkhardt AM, Homey B. Homeostatic chemokine receptors and organ-specific metastasis. Nat Rev Immunol,2011;11(9):597-606.

    [3]

    Lu Y, Wang J, Xu Y, et al. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro. Mol Cancer Res,2008;6(4):546-554.

    [4]

    Hojo S, Koizumi K, Tsuneyama K, et al. High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer. Cancer Res,2007;67(10):4725-4731.

    [5]

    Gutwein P, Schramme A, Sinke N, et al. Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients. Eur J Cancer,2009;45(3):478-489.

    [6]

    Wang J, Lu Y, Koch AE, et al. CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway. Cancer Res,2008;68(24):10367-10376.

    [7]

    Ludwig A, Hundhausen C, Lambert MH, et al. Metalloproteinase inhibitors for the disintegrin-like metalloproteinases ADAM10 and ADAM17 that differentially block constitutive and phorbol ester-inducible shedding of cell surface molecules. Comb Chem High Throughput Screen,2005;8(2):161-171.

    [8]

    Davison Z, de Blacquière GE, Westley BR, et al. Insulin-like growth factor-dependent proliferation and survival of triple-negative breast cancer cells:implications for therapy. Neoplasia,2011;13(6):504-515.

计量
  • 文章访问数:  3670
  • HTML全文浏览量:  151
  • PDF下载量:  31
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-01-03
  • 修回日期:  2013-03-06
  • 发布日期:  2013-07-19

目录

    /

    返回文章
    返回